Literature DB >> 10665491

Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.

S M Solano1, D W Miller, S J Augood, A B Young, J B Penney.   

Abstract

Mutations in the alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) genes have been linked to some cases of familial Parkinson's disease. To provide insight into how these genes may relate to each other and contribute to the pathology of Parkinson's disease, their expression was examined in normal human brain. Tissue sections from multiple regions of 11 normal human brains were hybridized with radiolabeled and digoxygenin-labeled cRNA probes for alpha-synuclein, parkin, and UCH-L1 mRNA. Expression of each of these three genes was predominantly neuronal. Alpha-synuclein and parkin mRNAs were expressed in a restricted number of brain regions, whereas UCH-L1 mRNA was more uniformly expressed throughout brain. The melanin-containing dopamine neurons of the substantia nigra had particularly robust expression. The expression patterns of alpha-synuclein and parkin mRNAs were similar, suggesting that these two proteins may be involved in common pathways contributing to the pathophysiology of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10665491

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  56 in total

Review 1.  Emerging therapies in the pharmacological treatment of Parkinson's disease.

Authors:  Amos D Korczyn; Miri Nussbaum
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Ischemic injury and faulty gene transcripts in the brain.

Authors:  P K Liu; R G Grossman; C Y Hsu; C S Robertson
Journal:  Trends Neurosci       Date:  2001-10       Impact factor: 13.837

Review 3.  Etiology of Parkinson's disease: Genetics and environment revisited.

Authors:  Kathy Steece-Collier; Eleonora Maries; Jeffrey H Kordower
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

Review 4.  Transcripts of damaged genes in the brain during cerebral oxidative stress.

Authors:  Philip K Liu; Tarun Arora
Journal:  J Neurosci Res       Date:  2002-12-15       Impact factor: 4.164

5.  Parkin transcript variants in rat and human brain.

Authors:  Velia Dagata; Sebastiano Cavallaro
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

6.  Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies.

Authors:  He-Jin Lee; Ji-Eun Suk; Christina Patrick; Eun-Jin Bae; Ji-Hoon Cho; Sangchul Rho; Daehee Hwang; Eliezer Masliah; Seung-Jae Lee
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

7.  Point mutation in the parkin gene on patients with Parkinson's disease.

Authors:  Tao Wang; Zhihou Liang; Shenggang Sun; Xuebing Cao; Hai Peng; Fei Cao; Hongjin Liu; E-tang Tong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

8.  Target genes of neuron-restrictive silencer factor are abnormally up-regulated in human myotilinopathy.

Authors:  Marta Barrachina; Jesús Moreno; Salvador Juvés; Dolores Moreno; Montse Olivé; Isidre Ferrer
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

Review 9.  Neurobiology of alpha-synuclein.

Authors:  Kostas Vekrellis; Hardy J Rideout; Leonidas Stefanis
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

10.  Merging mouse transcriptome analyses with Parkinson's disease linkage studies.

Authors:  Daniel Gherbassi; Lavinia Bhatt; Sandrine Thuret; Horst H Simon
Journal:  DNA Res       Date:  2007-05-23       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.